Insilico Medicine launches 'Longevity Vaccines' program to tackle aging with AI
rand_longevity · x · 2026-09-19
- AI drug discovery company Insilico Medicine announced a research program called "Longevity Vaccines," aiming to use AI to develop interventions targeting aging itself.
- The post links to a diagram explaining how the program would work; public details are currently limited to the announcement itself.
Related event: Insilico Medicine Launches AI-Driven Longevity Vaccine Program(2 posts)→
More from Research
- Running AI training on unsupported AMD MI50s: patched ROCm and a Vulkan training stack — Savantskie1 · 2026-09-19
- AI acknowledgments in arXiv math preprints jump from 4% to 25% in four months — burny_tech · 2026-09-19
- MIT-shared paper argues LLMs can't be conscious without brain-like analog computation — burny_tech · 2026-09-19
- PhD student asks: what's the JMLR submission experience like these days? — d_edge_sword · 2026-09-19
- Alibaba open-sources medical AI model that detects cancer and nearly 150 conditions — giveen · 2026-09-19
- In the era of AI-written papers, this researcher writes ICLR intros with zero AI — benno_krojer · 2026-09-19